BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Arslan N, Yılmaz Ö, Demiray-Gürbüz E. Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection. World J Gastroenterol 2017; 23(16): 2854-2869 [PMID: 28522904 DOI: 10.3748/wjg.v23.i16.2854]
URL: https://www.wjgnet.com/1007-9327/full/v23/i16/2854.htm
Number Citing Articles
1
Leila Lormohammadi, Farhad Nikkhahi, Shahin Bolori, Ali Akbar Karami, Sepideh Hajian, Neda Rad, Amir Peymani, Rasoul Samimi. High level of resistance to metronidazole and clarithromycin among Helicobacter pylori clinical isolates in Qazvin province, IranGene Reports 2022; 26: 101494 doi: 10.1016/j.genrep.2022.101494
2
Masoud Keikha, Mohsen Karbalaei. Prevalence of antibiotic heteroresistance associated with Helicobacter pylori infection: A systematic review and meta-analysisMicrobial Pathogenesis 2022; : 105720 doi: 10.1016/j.micpath.2022.105720
3
Sho Suzuki, Mitsuru Esaki, Chika Kusano, Hisatomo Ikehara, Takuji Gotoda. Development of <i>Helicobacter pylori</i> treatment: How do we manage antimicrobial resistance?World Journal of Gastroenterology 2019; 25(16): 1907-1912 doi: 10.3748/wjg.v25.i16.1907
4
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik. Current Status of the Third-LineHelicobacter pyloriEradicationGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6523653
5
Yan Zhao, Yang Li, Zhixian Luan, Cuiping Ma, Lin Yang, Wang Zhang, Chao Shi. Establishment of a TaqMan-MGB probe multiplex real-time PCR system for one-step levofloxacin and clarithromycin resistant Helicobacter pylori detectionJournal of Microbiological Methods 2022; 192: 106393 doi: 10.1016/j.mimet.2021.106393
6
Juan Bueno. Preclinical Evaluation of Antimicrobial NanodrugsNanotechnology in the Life Sciences 2020; : 1 doi: 10.1007/978-3-030-43855-5_1
7
Mohammad Zamani, Arash Rahbar, Javad Shokri-Shirvani. Resistance of <i>Helicobacter pylori</i> to furazolidone and levofloxacin: A viewpointWorld Journal of Gastroenterology 2017; 23(37): 6920-6922 doi: 10.3748/wjg.v23.i37.6920
8
Nilanjana Das, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal. Probiotics in the Prevention and Management of Human Diseases2022; : 281 doi: 10.1016/B978-0-12-823733-5.00001-5
9
Ahmed Megahed Abouwarda, Tarek Abdelmonem Ismail, Wael Mohamed Abu El-Wafa, Ahmed Hassan Ibrahim Faraag. Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pyloriWorld Journal of Microbiology and Biotechnology 2022; 38(6) doi: 10.1007/s11274-022-03289-2
10
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization RegionsGastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
11
Nuzhat Qureshi, Ping Li, Qing Gu. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?Applied Microbiology and Biotechnology 2019; 103(4): 1573 doi: 10.1007/s00253-018-09580-3
12
Helia Alavifard, Nasrin Mirzaei, Abbas Yadegar, Kaveh Baghaei, Sinéad Marian Smith, Amir Sadeghi, Mohammad Reza Zali. Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional StudyCurrent Microbiology 2021; 78(1): 244 doi: 10.1007/s00284-020-02295-7
13
Luis Fernando Valladales-Restrepo, Yessenia Correa-Sánchez, Brayan Stiven Aristizábal-Carmona, Jorge Enrique Machado-Alba. Treatment regimens used in the management of Helicobacter pylori in ColombiaThe Brazilian Journal of Infectious Diseases 2022; 26(1): 102331 doi: 10.1016/j.bjid.2022.102331
14
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategiesCritical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
15
Jonathon P Schubert, Jessica Gehlert, Christopher K Rayner, Ian C Roberts‐Thomson, Sam Costello, Arduino A Mangoni, Robert V Bryant. Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta‐analysis Journal of Gastroenterology and Hepatology 2021; 36(6): 1450 doi: 10.1111/jgh.15352
16
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?Revista de Gastroenterología de México (English Edition) 2022; 87(3): 330 doi: 10.1016/j.rgmxen.2022.06.003
17
Lou Yu, Laisheng Luo, Xiaohua Long, Xiao Liang, Yingjie Ji, Qi Chen, Yanyan Song, Xiaobo Li, David Y. Graham, Hong Lu. Susceptibility-guided therapy for Helicobacter pylori infection treatment failuresTherapeutic Advances in Gastroenterology 2019; 12: 175628481987492 doi: 10.1177/1756284819874922
18
Ying‐Ying Han, Hui Long, Ya Lin, Qiong He, Wei‐Gang Chen, Xiang‐Wu Ding, Lin Zhou, Ping An, Fen Wang, Zhen‐Yu Zhang, Yun‐Lian Hu, Pei‐Yuan Li. Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study Helicobacter 2022;  doi: 10.1111/hel.12922
19
Behtash G. Nezami, Mehul Jani, David Alouani, Daniel D. Rhoads, Navid Sadri, Andrew B. Onderdonk. Helicobacter pylori Mutations Detected by Next-Generation Sequencing in Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens Are Associated with Treatment FailureJournal of Clinical Microbiology 2019; 57(7) doi: 10.1128/JCM.01834-18
20
Aalaa Mahgoub Albasha, Maram M. Elnosh, Esraa Hassan Osman, Duha M. Zeinalabdin, Amira A. M. Fadl, Musa Abdalla Ali, Hisham N. Altayb. Helicobacter pylori 23S rRNA gene A2142G, A2143G, T2182C, and C2195T mutations associated with clarithromycin resistance detected in Sudanese patientsBMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02096-3
21
Éva Kocsmár, György Miklós Buzás, Ildikó Szirtes, Ildikó Kocsmár, Zsófia Kramer, Attila Szijártó, Petra Fadgyas-Freyler, Kató Szénás, Massimo Rugge, Matteo Fassan, András Kiss, Zsuzsa Schaff, Gergely Röst, Gábor Lotz. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolidesNature Communications 2021; 12(1) doi: 10.1038/s41467-021-22557-7
22
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trialJournal of the Formosan Medical Association 2022; 121(8): 1450 doi: 10.1016/j.jfma.2021.10.011
23
Denise Brennan, Colm O’Morain, Deirdre McNamara, Sinéad M. Smith. Helicobacter PyloriMethods in Molecular Biology 2021; 2283: 29 doi: 10.1007/978-1-0716-1302-3_4
24
Rongli Cui, Zhiqiang Song, Baojun Suo, Xueli Tian, Yan Xue, Lingmei Meng, Zhanyue Niu, Zhu Jin, Hejun Zhang, Liya Zhou. Correlation Analysis Among Genotype Resistance, Phenotype Resistance and Eradication Effect of Helicobacter pyloriInfection and Drug Resistance 2021; : 1747 doi: 10.2147/IDR.S305996
25
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?Revista de Gastroenterología de México 2022; 87(3): 330 doi: 10.1016/j.rgmx.2022.01.007
26
Chao Ran Ji, Jing Liu, Yue Yue Li, Chen Qiao, Jun Yan Qu, Jun Nan Hu, Min Juan Lin, Rui Ji, Li Xiang Li, Xiu Li Zuo, Yan Qing Li. Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial Journal of Digestive Diseases 2020; 21(10): 549 doi: 10.1111/1751-2980.12934
27
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALHAES, Décio CHINZON, Marcelo CURY, Gerson DOMINGUES, Jorge Luiz JORGE, Ismael MAGUILNIK, Frederico Passos MARINHO, Joaquim Prado de MORAES-FILHO, José Miguel Luz PARENTE, Celso Mirra de PAULA-E-SILVA, José PEDRAZZOLI-JÚNIOR, Ana Flávia Passos RAMOS, Heinrich SEIDLER, José Nonato SPINELLI, José Vitor ZIR. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTIONArquivos de Gastroenterologia 2018; 55(2): 97 doi: 10.1590/s0004-2803.201800000-20
28
Azizollah Yousefi, Shahryar Eslami, Samileh Noorbakhsh, Morteza Haghighi, Leila TaheriNia, Fahimeh Ehsanipour, Sarvenaz Ashouri. The Resistance Rate of Helicobacter Pylori to Clarithromycin and Main Mutations on Bacterial Genomic Responsible for Bacterial Resistance: A Comparative Study in Children and Adults, Tehran and IranInfectious Disorders - Drug Targets 2019; 19(4): 394 doi: 10.2174/1871526518666181012113052
29
Chih-Ming Liang, Wei-Chen Tai, Pin-I Hsu, Deng-Chyang Wu, Chao-Hung Kuo, Feng-Woey Tsay, Chia-Long Lee, Kuan-Yang Chen, Seng-Kee Chuah. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from TaiwanTherapeutic Advances in Gastroenterology 2020; 13: 175628482097699 doi: 10.1177/1756284820976990
30
Takuji Gotoda, Chika Kusano, Sho Suzuki, Toshiki Horii, Ryoji Ichijima, Hisatomo Ikehara. Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in JapanJournal of Gastroenterology 2020; 55(10): 969 doi: 10.1007/s00535-020-01709-4
31
Javier P. Gisbert. Empirical or susceptibility-guided treatment forHelicobacter pyloriinfection? A comprehensive reviewTherapeutic Advances in Gastroenterology 2020; 13: 175628482096873 doi: 10.1177/1756284820968736
32
Jing‐Jing Zhou, Xiao Shi, Shao‐Peng Zheng, Dan Tang, Ting Cai, Yao Yao, Fen Wang. Efficacy of bismuth‐based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large‐scale prospective, single‐center clinical trial in China Helicobacter 2020; 25(6) doi: 10.1111/hel.12755
33
Guofeng Yin, Shuxian Bie, Hongdan Gu, Xiaoli Shu, Wei Zheng, Kerong Peng, Hong Zhao, Fubang Li, Bo Chen, Benson O A Botchway, Marong Fang, Mizu Jiang. Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children Journal of Gastroenterology and Hepatology 2020; 35(8): 1331 doi: 10.1111/jgh.14980
34
Han-Yi Song, Long Zhou, Dong-yan Liu, Xin-Jie Yao, Yan Li. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing ResearchGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9379480
35
Te-Fu Lin, Ping-I Hsu. Second-line rescue treatment of <i>Helicobacter pylori</i> infection: Where are we now?World Journal of Gastroenterology 2018; 24(40): 4548-4553 doi: 10.3748/wjg.v24.i40.4548
36
Bea Van den Poel, Sarah Gils, Isabel Micalessi, Saskia Carton, Paul Christiaens, Pieter-Jan Cuyle, Veerle Moons, Gust Van Olmen, Annick Smismans, Claire Bourgain, Peter Bossuyt, Johan Frans. Molecular detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies: a prospective evaluation of RIDA®GENE Helicobacter pylori assayActa Clinica Belgica 2021; 76(3): 177 doi: 10.1080/17843286.2019.1685741
37
Sabrina Grando Cordeiro, Rafaela Ziem, Ytan Andreine Schweizer, Bruna Costa, Daniel Kuhn, Peterson Haas, Ani Caroline Weber, Daiane Heidrich, Eduardo Miranda Ethur, Clarice Steffens, Lucélia Hoehne. Degradation of micropollutant cephalexin by ultraviolet (UV) and assessment of residual antimicrobial activity of transformation productsWater Science and Technology 2021; 84(2): 374 doi: 10.2166/wst.2021.170
38
Sho Suzuki, Takuji Gotoda, Chika Kusano, Hisatomo Ikehara, Ryoji Ichijima, Motoki Ohyauchi, Hirotaka Ito, Masashi Kawamura, Yohei Ogata, Masahiko Ohtaka, Moriyasu Nakahara, Koichi Kawabe. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in JapanGut 2020; 69(6): 1019 doi: 10.1136/gutjnl-2019-319954
39
Evelyn Pedroso Toscano, Fernanda Fernandes Madeira, Mayra Pinheiro Dutra-Rulli, Luiz Otavio Maia Gonçalves, Marcela Alcântara Proença, Viviane Silva Borghi, Aline Cristina Targa Cadamuro, Giselda Warick Mazzale, Ricardo Acayaba, Ana Elizabete Silva. Epidemiological and Clinical-Pathological Aspects of Helicobacter pylori Infection in Brazilian Children and AdultsGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/8454125
40
Menizibeya Osain Welcome. Gastrointestinal Physiology2018; : 991 doi: 10.1007/978-3-319-91056-7_14
41
Samantha Flores-Treviño, Soraya Mendoza-Olazarán, Paola Bocanegra-Ibarias, Héctor Jesús Maldonado-Garza, Elvira Garza-González. Helicobacter pyloridrug resistance: therapy changes and challengesExpert Review of Gastroenterology & Hepatology 2018; 12(8): 819 doi: 10.1080/17474124.2018.1496017
42
Tian Geng, Zhong-Su Yu, Xi-Xi Zhou, Bo Liu, Hui-Hua Zhang, Zhong-Yue Li. Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing, ChinaEuropean Journal of Pediatrics 2022; 181(7): 2715 doi: 10.1007/s00431-022-04456-1
43
Nader Nemr, Rania M. Kishk, Ayman Salem, Mohamed O. Abdalla, Noha M. Abd El-Fadeal, Nashaat M. Soliman. Genotypic detection of metronidazole and clarithromycin resistance in dyspeptic patients with helicobacter pyloriEnvironmental Science and Pollution Research 2022; 29(27): 41467 doi: 10.1007/s11356-021-18198-4
44
Tzu-Hsin Huang, Shih-Cheng Yang, Wei-Chen Tai, Chih-Ming Liang, Chung-Mou Kuo, Chih-Chien Yao, Cheng-Kun Wu, Yuan-Hung Kuo, Yeh-Pin Chou, Chen-Hsiang Lee, Keng-Liang Wu, Seng-Kee Chuah. The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistanceBiomedical Journal 2021; 44(6): S275 doi: 10.1016/j.bj.2020.11.012
45
Irina Yurievna Kolesnikova, Irina Vyacheslavovna Ivakhnenko, Anzhelika Viktorovna Ponomareva, Sergey Ivanovich Krayushkin. Modern aspects of eradication therapySpravočnik vrača obŝej praktiki (Journal of Family Medicine) 2020; (12): 36 doi: 10.33920/med-10-2012-05
46
Olga P. Nyssen, Marta Espada, Javier P. Gisbert. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-AnalysisFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.913436
47
Jina Vazirzadeh, Jamal Falahi, Sharareh Moghim, Tahmineh Narimani, Rahmatollah Rafiei, Vajihe Karbasizadeh. Molecular Assessment of Resistance to Clarithromycin in Helicobacter pylori Strains Isolated from Patients with Dyspepsia by Fluorescent In Situ Hybridization in the Center of IranBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2304173
48
Alexander Vanden Bulcke, Bruno Waked, Lise Haems, Guy Lambrecht, Anne-Sophie Hervent, Gudrun Alliet, Filip Baert, Steven Vervaeke. Antimicrobial resistance of Helicobacter pylori in West Flanders – Belgium: an observational cross-sectional studyActa Clinica Belgica 2022; 77(2): 360 doi: 10.1080/17843286.2021.1872307
49
Chang Seok Bang, Hyun Lim, Hae Min Jeong, Woon Geon Shin, Jae Ho Choi, Jae Seung Soh, Ho Suk Kang, Young Joo Yang, Ji Taek Hong, Suk Pyo Shin, Ki Tae Suk, Jae Jun Lee, Gwang Ho Baik, Dong Joon Kim. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infectionGut Microbes 2020; 11(5): 1314 doi: 10.1080/19490976.2020.1754118
50
Agnes Tving Stauning, Rie Louise Møller Nordestgaard, Tove Havnhøj Frandsen, Leif Percival Andersen. Helicobacter pylori [Working Title]2018;  doi: 10.5772/intechopen.80662